Journey Medical Corporation (DERM) vs Glass House Brands Inc. (GLAS)

Journey Medical Corporation and Glass House Brands Inc. are both Drug Manufacturers Specialty & Generic companies. Glass House Brands Inc. is the larger, with a market value of $172.7M against $121.4M — 1.4× the size. Journey Medical Corporation grew revenue faster over the last twelve months: 20.9% against −15.4%. Journey Medical Corporation has the higher net margin (−8.95% vs −36.2%) and the higher return on invested capital (−5.89% vs −23.4%). Across the 17 metrics below, Journey Medical Corporation leads on 11 and Glass House Brands Inc. on 6.

Valuation

Metric DERM GLAS Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 1.73 1.14 2.08
P/B 3.68 2.79 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA 67.73 n/m 12.22
EV/Sales 1.73 1.35 2.87
Earnings yield (5.12%) (33.33%) (15.94%)
Free cash flow yield (19.02%) (18.18%) 0.00%

Profitability

Metric DERM GLAS Drug Manufacturers Specialty & Generic median
Gross margin 65.45% 31.97% 53.51%
Operating margin (4.41%) (23.18%) 0.00%
Net margin (8.95%) (36.19%) (2.45%)
Free cash flow margin (10.99%) (20.78%) 0.00%
Return on equity (23.77%) (74.02%) (0.80%)
Return on assets (6.80%) (19.78%) (1.67%)
Return on invested capital (5.89%) (23.36%) 0.00%

Growth

Metric DERM GLAS Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 20.89% (15.38%) 5.22%
EPS growth (last fiscal year) 34.72% (161.90%) 42.91%
Revenue growth, 5-year CAGR 6.79% — 7.24%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric DERM GLAS Drug Manufacturers Specialty & Generic median
Debt to equity 0.79 0.77 0.04
Current ratio 1.59 1.33 2.41
Net debt to EBITDA (0.35) (64.84) 1.01

Dividend

Metric DERM GLAS Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric DERM GLAS Drug Manufacturers Specialty & Generic median
Market cap 121.36m 172.67m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack